全文获取类型
收费全文 | 1676篇 |
免费 | 229篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 64篇 |
妇产科学 | 42篇 |
基础医学 | 193篇 |
口腔科学 | 44篇 |
临床医学 | 268篇 |
内科学 | 421篇 |
皮肤病学 | 51篇 |
神经病学 | 99篇 |
特种医学 | 37篇 |
外科学 | 243篇 |
综合类 | 4篇 |
一般理论 | 1篇 |
预防医学 | 166篇 |
眼科学 | 24篇 |
药学 | 75篇 |
中国医学 | 2篇 |
肿瘤学 | 143篇 |
出版年
2024年 | 4篇 |
2023年 | 43篇 |
2022年 | 11篇 |
2021年 | 44篇 |
2020年 | 47篇 |
2019年 | 46篇 |
2018年 | 98篇 |
2017年 | 65篇 |
2016年 | 60篇 |
2015年 | 81篇 |
2014年 | 70篇 |
2013年 | 72篇 |
2012年 | 104篇 |
2011年 | 101篇 |
2010年 | 80篇 |
2009年 | 114篇 |
2008年 | 89篇 |
2007年 | 78篇 |
2006年 | 79篇 |
2005年 | 65篇 |
2004年 | 61篇 |
2003年 | 53篇 |
2002年 | 66篇 |
2001年 | 66篇 |
2000年 | 53篇 |
1999年 | 46篇 |
1998年 | 12篇 |
1997年 | 18篇 |
1996年 | 12篇 |
1995年 | 13篇 |
1994年 | 12篇 |
1993年 | 4篇 |
1992年 | 18篇 |
1991年 | 20篇 |
1990年 | 15篇 |
1989年 | 13篇 |
1988年 | 7篇 |
1987年 | 10篇 |
1986年 | 12篇 |
1985年 | 7篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1980年 | 2篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有1911条查询结果,搜索用时 15 毫秒
1.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
2.
3.
Amalia Moreno Concepción Montón Yolanda Belmonte Miguel Gallego Xavier Pomares Jordi Real 《Archivos de bronconeumologia》2009,45(4):181-185
ObjectiveThe objective of this study was to assess the causes of death and risk factors for mortality in a cohort of patients with severe chronic obstructive pulmonary disease (COPD).Patients and methodsWe studied 203 patients with severe COPD (forced expiratory volume in 1 second [FEV1] <50%), who were attended in our respiratory department day hospital (2001-2006). Clinical variables were recorded on inclusion, and clinical course and causes of death were retrospectively reviewed.ResultsThe mean (SD) age of patients was 69 (8) years and the mean FEV1 was 30.8% (8.2%). One-hundred and nine patients died (53.7%); death was attributed to respiratory causes in 72 (80.9%), with COPD exacerbation being the most frequent specific cause within this category (48.3%). During follow-up, 18.7% required admission to the intensive care unit (ICU). Survival at 1, 3, and 5 years was 80%, 53%, and 26%, respectively. The multivariate analysis showed that mortality was associated with age, stage IV classification according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), cor pulmonale, and hospital admission during the year prior to inclusion. Need for admission to the ICU during follow-up was a factor independently associated with higher mortality.ConclusionsMortality in patients with severe COPD was high and exacerbation of the disease was one of the most frequent causes of death. Age, GOLD stage, cor pulmonale, prior admission to hospital, and need for admission to the ICU during follow-up were independent predictors of mortality. 相似文献
4.
5.
6.
7.
8.
9.
10.